Published in Exp Cell Res on February 20, 2015
Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 101.91
Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci U S A (2005) 6.26
Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell (2010) 5.08
Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest (2001) 3.37
Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord (2006) 3.25
Control of bone mass and remodeling by PTH receptor signaling in osteocytes. PLoS One (2008) 2.96
Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater (2008) 2.54
High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med (2006) 2.09
Identification of differentially expressed genes between osteoblasts and osteocytes. Bone (2009) 1.97
GO-Elite: a flexible solution for pathway and ontology over-representation. Bioinformatics (2012) 1.91
The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats. Endocrinology (1997) 1.81
Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis. J Biol Chem (2007) 1.79
Vascular biology and the skeleton. J Bone Miner Res (2005) 1.75
The osteoblast: an insulin target cell controlling glucose homeostasis. J Bone Miner Res (2011) 1.70
Coagulation and innate immune responses: can we view them separately? Blood (2009) 1.61
Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics. J Biol Chem (2003) 1.53
Bone loss in inflammatory disorders. J Endocrinol (2009) 1.51
Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass. Proc Natl Acad Sci U S A (2008) 1.46
A single mutation in the 5-HT4 receptor (5-HT4-R D100(3.32)A) generates a Gs-coupled receptor activated exclusively by synthetic ligands (RASSL). J Biol Chem (2002) 1.42
Differentiation of osteoblasts and osteocytes from mesenchymal stem cells. Curr Stem Cell Res Ther (2008) 1.39
Col1a1-driven transgenic markers of osteoblast lineage progression. J Bone Miner Res (2001) 1.35
Transcriptional regulation of osteoblasts. Cells Tissues Organs (2008) 1.34
Conditional expression of a Gi-coupled receptor in osteoblasts results in trabecular osteopenia. Endocrinology (2007) 1.20
Deficiency of the G-protein alpha-subunit G(s)alpha in osteoblasts leads to differential effects on trabecular and cortical bone. J Biol Chem (2005) 1.19
Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis by DNA microarray. J Cell Biochem (2005) 1.15
Signaling networks that control the lineage commitment and differentiation of bone cells. Crit Rev Eukaryot Gene Expr (2009) 1.11
Fgf-9 is required for angiogenesis and osteogenesis in long bone repair. Proc Natl Acad Sci U S A (2010) 1.07
Insights in to the pathogenesis of axial spondyloarthropathy based on gene expression profiles. Arthritis Res Ther (2009) 1.07
Circulating insulin levels are related to bone density in normal postmenopausal women. Am J Physiol (1993) 1.05
Strain-dependent variations in the response of cancellous bone to ovariectomy in mice. J Bone Miner Res (2006) 1.04
The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response. Cancer Res (2006) 0.99
Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation. J Biol Chem (2006) 0.99
Osteocrin, a novel bone-specific secreted protein that modulates the osteoblast phenotype. J Biol Chem (2003) 0.98
Chondroadherin expression changes in skeletal development. Biochem J (1998) 0.94
Prostaglandin E2 signals through PTGER2 to regulate sclerostin expression. PLoS One (2011) 0.92
Gs G protein-coupled receptor signaling in osteoblasts elicits age-dependent effects on bone formation. J Bone Miner Res (2010) 0.92
Embryonic expression pattern of the murine figf gene, a growth factor belonging to platelet-derived growth factor/vascular endothelial growth factor family. Mech Dev (1998) 0.91
Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+. Exp Cell Res (1998) 0.89
Phenotypic characteristics of bone in carbonic anhydrase II-deficient mice. Calcif Tissue Int (2008) 0.89
The skeletal phenotype of chondroadherin deficient mice. PLoS One (2013) 0.87
Coagulation meets calcification: the vitamin K system. Int J Artif Organs (2009) 0.85
Bone chondroadherin promotes attachment of osteoblastic cells to solid-state substrates and shows affinity to collagen. Calcif Tissue Int (1996) 0.85
Ligand-mediated activation of an engineered gs g protein-coupled receptor in osteoblasts increases trabecular bone formation. Mol Endocrinol (2010) 0.83
Mineral composition is altered by osteoblast expression of an engineered G(s)-coupled receptor. Calcif Tissue Int (2011) 0.81